Drug Trial Radar · NCT00398281
Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer
Last checked: Nov 20, 2026Latest source record: Jan 10, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
450
Planned (sponsor's estimate)
Start
Nov 2006
Primary completion
Jul 2010
Study completion Sep 2012
Sponsor
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Nov 10, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Masking
- Double
- Primary purpose
- Diagnostic
- Who can join
- Male only, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Diagnostic procedures, such as ultrasound-guided biopsy, may help find prostate cancer. Dutasteride may improve the ability of ultrasound-guided biopsy to find prostate cancer. It is not yet known whether dutasteride followed by ultrasound-guided biopsy is more effective than a placebo followed by ultrasound-guided biopsy in finding prostate cancer. PURPOSE: This randomized phase III trial is studying dutasteride and ultrasound-guided biopsy to see how well they find prostate cancer compared with a placebo and ultrasound-guided biopsy.
Conditions
- Prostate Cancer
Interventions
dutasterideDrug
Given orally
placeboOther
Given orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of short-term dutasteride in improving prostate cancer detection
- Detection rate of prostate cancer
- Cost effectiveness of contrast-enhanced ultrasound
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.